ALVO gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. ALVO has a medium profitability rating, but doesn't score so well on its financial health evaluation. ALVO is not priced too expensively while it is growing strongly. Keep and eye on this one!

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

ALVO had positive earnings in the past year.
ALVO had a negative operating cash flow in the past year.
ALVO had negative earnings in each of the past 5 years.
ALVO had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With an excellent Return On Assets value of 4.93%, ALVO belongs to the best of the industry, outperforming 91.24% of the companies in the same industry.
ALVO's Return On Invested Capital of 3.10% is amongst the best of the industry. ALVO outperforms 90.29% of its industry peers.

		Industry Rank	Sector Rank
ROA	4.93%
ROE	N/A
ROIC	3.1%

ROA(3y)-46.35%

ROA(5y)-38.37%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin of ALVO (12.12%) is better than 92.00% of its industry peers.
With an excellent Operating Margin value of 7.57%, ALVO belongs to the best of the industry, outperforming 90.29% of the companies in the same industry.
With a decent Gross Margin value of 55.59%, ALVO is doing good in the industry, outperforming 77.33% of the companies in the same industry.

		Industry Rank	Sector Rank
OM	7.57%
PM (TTM)	12.12%
GM	55.59%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALVO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ALVO has more shares outstanding
ALVO has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -1.04, we must say that ALVO is in the distress zone and has some risk of bankruptcy.
ALVO has a Altman-Z score (-1.04) which is in line with its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-1.04

ROIC/WACC0.49

WACC6.29%

2.3 Liquidity

ALVO has a Current Ratio of 1.42. This is a normal value and indicates that ALVO is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.42, ALVO is not doing good in the industry: 81.52% of the companies in the same industry are doing better.
A Quick Ratio of 0.74 indicates that ALVO may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.74, ALVO is doing worse than 87.62% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.42
Quick Ratio	0.74

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 122.99% over the past year.
The Revenue has grown by 426.84% in the past year. This is a very strong growth!
The Revenue has been growing by 42.86% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)122.99%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%0%

Revenue 1Y (TTM)426.84%

Revenue growth 3Y131.44%

Revenue growth 5Y42.86%

Sales Q2Q%0%

3.2 Future

Based on estimates for the next years, ALVO will show a very strong growth in Earnings Per Share. The EPS will grow by 41.54% on average per year.
The Revenue is expected to grow by 33.06% on average over the next years. This is a very strong growth

EPS Next Y116.02%

EPS Next 2Y57.41%

EPS Next 3Y41.54%

EPS Next 5YN/A

Revenue Next Year28.26%

Revenue Next 2Y36.14%

Revenue Next 3Y33.06%

Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 26.30, ALVO can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of ALVO indicates a rather cheap valuation: ALVO is cheaper than 93.90% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of ALVO to the average of the S&P500 Index (27.21), we can say ALVO is valued inline with the index average.
With a Price/Forward Earnings ratio of 12.65, ALVO is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALVO indicates a rather cheap valuation: ALVO is cheaper than 97.52% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 24.26. ALVO is valued slightly cheaper when compared to this.

		Industry Rank	Sector Rank
PE	26.3
Fwd PE	12.65

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALVO is valued cheaply inside the industry as 92.00% of the companies are valued more expensively.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	36.08

4.3 Compensation for Growth

ALVO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALVO's earnings are expected to grow with 41.54% in the coming years. This may justify a more expensive valuation.